Blythin; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blythin; David J..The latest application filed is for "maleate, tosylate, fumarate and oxalate salts of 5-(1-(s)-amino-2-hydroxyethyl)-n-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore".

Company Profile

0.15.3

Blythin; David J. - North Caldwell NJ
Blythin; David J. - Caldwell NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore Grant 7,956,189 - Chen , et al. June 7, 2	2011-06-07
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore App 20080108818 - Chen; Xiaoming ; et al.	2008-05-08
Selective neurokinin antagonists Grant 6,635,630 - Shih , et al. October 21, 2	2003-10-21
Selective neurokinin antagonists App 20030064980 - Shih, Neng-Yang ; et al.	2003-04-03
Selective Neurokinin Antagonists App 20020123491 - Shih, Neng-Yang ; et al.	2002-09-05
Selective neurokinin antagonists Grant 6,436,928 - Shih , et al. August 20, 2	2002-08-20
Piperazino derivatives as neurokinin antagonists Grant 5,968,929 - Blythin , et al. October 19, 1	1999-10-19
Piperazino derivatives as neurokinin antagonists Grant 5,869,488 - Shue , et al. February 9, 1	1999-02-09
Piperazino derivatives as neurokinin antagonists Grant 5,798,359 - Shue , et al. August 25, 1	1998-08-25
Piperazino derivatives as neurokinn antagonists Grant 5,795,894 - Shue , et al. August 18, 1	1998-08-18
Piperazino derivatives as neurokinin antagonists Grant 5,719,156 - Shue , et al. February 17, 1	1998-02-17
1-substituted naphthyridine and pyridopyrazine derivatives Grant 5,037,826 - Blythin , et al. August 6, 1	1991-08-06
Aryl-alkynoic, alkenoic or alkanoic compounds and compositions useful as antiallergy and anti-inflammatory agents Grant 4,897,397 - Shih , et al. January 30, 1	1990-01-30
Anti-allergic composition containing zwitterionic bicyclic compounds Grant 4,782,067 - Blythin , et al. November 1, 1	1988-11-01
Naphthyridine derivatives and method for treating allergic reactions Grant 4,775,686 - Blythin , et al. October 4, 1	1988-10-04
Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents Grant 4,760,073 - Blythin , et al. July 26, 1	1988-07-26
Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents Grant 4,684,727 - Blythin , et al. August 4, 1	1987-08-04
2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents Grant 4,272,535 - Blythin June 9, 1	1981-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.